Gallentes, Lyca L.
HRN: 19-25-64 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2024
CEFUROXIME 1.5GM (VIAL)
11/07/2024
11/13/2024
IV
1.5g
Q8
D&C
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes